TSTickerStarGet alerts

VisionWave Special Meeting November 19 to Vote on Authorized Share Increase, Reverse Split Authority, $40M Potential Offering, and Yorkville Issuance Approval

VisionWave Holdings is soliciting stockholder approval at a special meeting on November 19, 2026 for six proposals related to the company's capital structure and financing arrangements with YA II PN, Ltd. (Yorkville). The proposals include increasing authorized common shares from 150,000,000 to 2,000,000,000; granting reverse stock split authority up to 1-for-1,000 ratio through December 31, 2028; approving a 2026 Employee Incentive Plan reserving 100,000,000 shares; approving Yorkville share issuances in excess...

Share this story

Key takeaways

  • Authorized share increase: Board seeks to increase authorized common shares from 150,000,000 to 2,000,000,000 to satisfy reservation obligations under Yorkville debentures, the SEPA commitment, the 2026 EIP, and a potential public offering

  • Reverse stock split authority: Board seeks discretion to effect one or more reverse stock splits at ratios up to 1-for-1,000 through December 31, 2028 to maintain Nasdaq $1.00 minimum bid price compliance and increase available authorized shares

  • 2026 Employee Incentive Plan: Company proposes to reserve 100,000,000 shares for employee equity awards, representing approximately 92.6% dilution on a fully diluted basis as of the record date

  • Yorkville financing: Company needs stockholder approval to issue shares under the SEPA, notes, debentures and warrants held by Yorkville in excess of the 19.99% Exchange Cap, and to reduce conversion floor prices to $1.00 per share to avoid cash payment defaults on approximately $19.3 million of obligations maturing in Q1 2027

  • Potential public offering: Company seeks approval to issue up to $40,000,000 of securities in registered direct offerings at discounts up to 80% to the Nasdaq Minimum Price, with warrants containing exercise price reset provisions, floor prices as low as 25% of Minimum Price, and zero cash exercise provisions

  • Shareholder dilution risk: Multiple proposals, if approved, could result in issuance of very large numbers of shares relative to the 3,245,660 shares currently outstanding, potentially exceeding 500% dilution in certain scenarios

Key metrics

Outstanding shares as of record dateOctober 19, 2026
3,245,660
Stock priceOctober 23, 2026
$3.72 per share
SEPA commitment availableas of October 7, 2026
approximately $35,000,000
Yorkville obligations outstandingas of record date
$19,313,672
2026 EIP shares reservedupon approval
100,000,000
Potential offering sizewithin 3 months after special meeting
up to $40,000,000

Disclosure changes

  • Capital structure and authorized shares

    Company proposes to increase authorized common stock from 150,000,000 to 2,000,000,000 shares, which the Board states is necessary to satisfy reservation obligations under Yorkville debentures (requiring shares sufficient for full conversion at the $1.00 floor price, potentially 20 million or more shares), the remaining SEPA commitment, the 2026 EIP (100,000,000 shares), and a potential public offering (up to 760,000,000 shares)

    The proposed increase would enable the Company to access substantial equity capital but would also enable issuance of shares that could dilute existing stockholders by more than 500% in certain scenarios
  • Reverse stock split authority

    Board seeks authority to effect one or more reverse stock splits at ratios from 1-for-2 to 1-for-1,000 through December 31, 2028, which would supersede the prior authority approved September 1, 2026 at ratios up to 1-for-250

    The expanded authority with wider ratio range provides the Board flexibility to address future Nasdaq minimum bid price compliance issues or create additional authorized share capacity, but also creates risk of substantial reverse split
  • Yorkville financing arrangements and floor price amendment

    Company is seeking stockholder approval to issue shares to Yorkville under the SEPA, July 2025 Note ($2.5M outstanding), February 2026 Note ($1.8M outstanding), Fourth and Fifth Debentures ($15M total outstanding), February 2026 Warrant (66,667 shares at $30.00), and July 2026 Warrant (90,000 shares at $100.00), in each case without regard to the 19.99% Exchange Cap and without the 500,000-share limitation from the February 2026 Approval. Additionally, the Company proposes to reduce the floor price under the Jul...

    The floor price reduction to $1.00 would allow Yorkville to convert outstanding obligations into significantly more shares than currently possible, potentially resulting in very substantial dilution if the stock price remains near current levels
  • 2026 Employee Incentive Plan

    Company proposes the 2026 Employee Incentive Plan reserving 100,000,000 shares of common stock for employee, director, and consultant equity awards, including incentive and non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, performance awards, and other equity-based compensation

    The 100,000,000 share reservation, together with existing awards and available shares, would represent approximately 92.6% dilution on a fully diluted basis. The Board states this is necessary to attract and retain talent in the defense technology, autonomy and AI sectors given limited cash resources
  • Potential registered offering parameters

    Company seeks approval for potential issuance of up to $40,000,000 of common stock and convertible/exercisable securities in one or more registered offerings (including registered direct offerings under the Form S-3 shelf and underwritten public offerings) at prices that may be at a discount up to 80% to the Nasdaq Minimum Price, with warrants potentially containing exercise price reset provisions (as low as 25% of Minimum Price), anti-dilution adjustments, floor prices, and zero cash exercise provisions, limite...

    The potential offering structure with aggressive pricing terms, warrant resets, and zero cash exercise provisions could result in very substantial dilution if the stock price declines, with the illustration showing potential dilution exceeding 5,000% of current shares outstanding
  • Nasdaq Listing Rule 5101 considerations

    The proxy statement extensively discusses Nasdaq's discretionary authority under Listing Rule 5101 regarding 'future priced securities' and notes that securities with warrant exercise price resets and zero cash exercise provisions have raised public interest concerns at Nasdaq, with some companies receiving delisting determinations. The Company acknowledges Nasdaq could require modification of terms, halt trading, or issue a delisting determination even if stockholders approve the proposal

    Even with stockholder approval, Nasdaq may exercise discretionary authority to delist or require restructuring of the potential offering terms due to the substantial dilution potential and reset provisions

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow VWAV in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert